Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Current ratio

Current ratio at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
21.3×+16.0×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
10.8×+2.3×
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
32.6×+16.8×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.0×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
4.1×-5.6×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
7.1×+1.0×

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×—
P/S5.6×+1.8×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

total current assets/total current liabilities=3.8×

Based on the most recent quarter.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's current ratio?
Kiniksa Pharmaceuticals International, plc (KNSA) reported current ratio of 3.8× in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's current ratio changed year-over-year?
Kiniksa Pharmaceuticals International, plc's current ratio increased by 3.7% year-over-year, from 3.7× to 3.8×.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's current ratio?
Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's current ratio has grown at a -18.4% compound annual growth rate (CAGR), from 10.5× to 3.8×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.